Exact Mass: 378.0672196
Exact Mass Matches: 378.0672196
Found 45 metabolites which its exact mass value is equals to given mass value 378.0672196,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid
C17H14O10 (378.05869440000004)
3,4,5-trihydroxy-6-({7-oxo-7h-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 4-hydroxy-7h-furo[3,2-g]chromen-7-one. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.
6-Bromo-1-ethoxy-1,8-dihydroaplysinopsin
C16H19BrN4O2 (378.06912939999995)
Anastatin A
anastatin B
jusmicranthin methyl ester|jusmicranthin methyl ether
5-(3,4-Dimethoxyphenyl)naphtho[2,3-d]-1,3-dioxole-6,7-dicarboxylic anhydride
Thiazolidine, 3-[(4-methyl-3-nitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
3-(4-Bromo[1,1-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthalenol
Vortioxetine hydrobromide
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Vortioxetine hydrobromide is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
(3,5-bis(trifluoromethyl)phenyl)(3,4-dimethoxyphenyl)methanone
2-[[3-(4-Methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetic acid ethyl ester
1-(4-Acetylphenyl)-3-[(4-nitrophenyl)sulfonylamino]urea
C15H14N4O6S (378.06340240000003)
(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-tert-butylsulfonylprop-2-enenitrile
N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide
5-fluoro-3-[(4-methoxyphenyl)sulfonylamino]-1H-indole-2-carboxylic acid methyl ester
5,7-Dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate
3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid
C17H14O10 (378.05869440000004)
5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate(1-)
An aryl sulfate oxoanion that is the conjugate base of 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate, obtained by deprotonation of the sulfo group; major species at pH 7.3.